Avulux

Avulux is a healthcare technology company focused on developing and distributing lenses that alleviate migraine and light sensitivity symptoms. Founded by Dr. Charles Posternack and David Efraim, Avulux launched its flagship product, the Avulux Migraine & Light Sensitivity Lenses, in 2018 after extensive clinical research. The lenses utilize patented technology to filter harmful light wavelengths linked to migraine attacks, providing effective relief while maintaining color neutrality and visual clarity. The company partners with over 200 independent eyecare providers and eight optical labs to ensure broad availability of its lenses across the United States and internationally. Avulux also offers training for eyecare professionals to help them fit and recommend the lenses to patients. In 2023, Avulux merged with Axon Optics to enhance its research capabilities and expand its distribution channels. The company targets individuals suffering from migraines and light sensitivity, positioning its lenses as essential tools for managing these conditions.

• Employees 23
• Founded 2019